Modeus and WellSky partner to deliver electronic controlled drug management to global markets
Australian healthcare software company Modeus is thrilled to announce a partnership with WellSky International Ltd, providers of the UK’s leading digital medicines management platform (Pharmacy, EPMA and Chemotherapy).
Under the agreement, WellSky will sell a branded version of HS8 called “WellSky CD Manager” to its customers in Ireland and the UK, with plans to extend to the Netherlands, Belgium, Norway, Sweden and South Africa in the future.
The solution eliminates the need for controlled drug paper records, which have been identified as a potential source of infection in recent reviews covering hospital hygiene and safety during the
pandemic. It is integrated with WellSky systems to deliver seamless controlled drug management while helping to improve governance and compliance.
Rob Tysall-Blay, CEO of Wellsky International, commented; “WellSky is delighted to partner with Modeus on this journey. CD Manager is an important new addition to the WellSky Medicines Management Platform and provides hospitals with a paperless solution for their controlled drug processes. We anticipate a great deal of interest in this latest expansion to the WellSky suite.
Carl Zufi, CEO of Modeus commented; We are very excited to be partnering with WellSky International to deliver our innovative controlled drug management platform to global markets.
WellSky International has a comprehensive medication management platform and WellSky CD Manager extends and compliments this to provide a fully integrated solution unmatched anywhere else. As the use of controlled drugs in hospitals continues to grow at a rapid rate, the need to move away from inefficient manual paper based systems is critical. WellSky CD Manager has been specifically designed to address this challenge.
About WellSky International
WellSky International Ltd is a wholly owned subsidiary of WellSky Inc which serves more than 14,000 client sites around the world — including hospital systems, blood banks, home health and hospice franchises, government agencies, and human services organisations. For more information on WellSky International Ltd visit www.wellsky.org
Modeus is thrilled to announce a partnership with Imprivata, a global Healthcare IT security company.
The HS8 integration with Imprivata Confirm ID, an identification workflow, will drive efficiencies by allowing users to confirm register entries within HS8 via card tap or fingerprint authentication instead of manually typing in usernames and passwords.
This partnership will also support secure access to HS8 by providing safeguards to help improve patient safety. This will be achieved by incorporating re-authentication for signing and witnessing across a range of hospital medication transactions. These include stock checks, stock transfers, receipt of stock as well as dispensing from pharmacy, ward and theatre areas.
Vet S8 is now integrated with Vet practice management software VetLinkSQL for the supply of controlled drugs to patients, receipt of controlled drugs from suppliers and transfers of controlled drugs to linked registers within Vet S8.
This means that when an invoice is raised in VetLinkSQL, the relevant controlled drug register data is automatically sent to the Vet S8 pending list, ready for the veterinarian to action.
When controlled drugs are receipted through VetLinkSQL the data will flow through to Vet S8, streamlining the receipt of controlled drug stock. The transfer of these medications to other locations (e.g vehicles) through Vetlink will also bring the relevant data across. No more double entry of data required!